High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer
Open Access
- 19 February 2008
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 98 (6), 1118-1124
- https://doi.org/10.1038/sj.bjc.6604256
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancerLung Cancer, 2008
- High Macrophage Infiltration along the Tumor Front Correlates with Improved Survival in Colon CancerClinical Cancer Research, 2007
- Macrophage and Mast-Cell Invasion of Tumor Cell Islets Confers a Marked Survival Advantage in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Macrophages Promote the Invasion of Breast Carcinoma Cells via a Colony-Stimulating Factor-1/Epidermal Growth Factor Paracrine LoopCancer Research, 2005
- Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2005
- Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With GefitinibJournal of Clinical Oncology, 2005
- Infiltrating immune cells, but not tumour cells, express FasL in non‐small cell lung cancer: No association with prognosis identified in 3‐year follow‐upInternational Journal of Cancer, 2002
- Production of Vascular Endothelial Growth Factor by Murine MacrophagesThe American Journal of Pathology, 1998
- The origin and function of tumor-associated macrophagesImmunology Today, 1992
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958